165 related articles for article (PubMed ID: 10469264)
1. The effect of non-antihypertensive doses of angiotensin converting enzyme inhibitor on myocardial necrosis and hypertrophy in young rats with renovascular hypertension.
Matsubara BB; Matsubara LS; Franco M; Padovani JC; Janicki JS
Int J Exp Pathol; 1999 Apr; 80(2):97-104. PubMed ID: 10469264
[TBL] [Abstract][Full Text] [Related]
2. Ramipril prevents left ventricular hypertrophy with myocardial fibrosis without blood pressure reduction: a one year study in rats.
Linz W; Schaper J; Wiemer G; Albus U; Schölkens BA
Br J Pharmacol; 1992 Dec; 107(4):970-5. PubMed ID: 1334756
[TBL] [Abstract][Full Text] [Related]
3. Myocardial fibrosis rather than hypertrophy induces diastolic dysfunction in renovascular hypertensive rats.
Matsubara LS; Matsubara BB; Okoshi MP; Franco M; Cicogna AC
Can J Physiol Pharmacol; 1997 Dec; 75(12):1328-34. PubMed ID: 9534942
[TBL] [Abstract][Full Text] [Related]
4. Left and right coronary circulation in left ventricular hypertrophy: effects of angiotensin converting enzyme inhibition.
Shimada Y; Avkiran M
Circ J; 2002 Dec; 66(12):1168-72. PubMed ID: 12499626
[TBL] [Abstract][Full Text] [Related]
5. Cardioprotective action of perindopril versus candesartan in renovascular hypertensive rats.
Nagai M; Horikoshi K; Izumi T; Seki S; Taniguchi M; Taniguchi I; Mochizuki S
Cardiovasc Drugs Ther; 2004 Sep; 18(5):353-62. PubMed ID: 15717137
[TBL] [Abstract][Full Text] [Related]
6. Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in rats.
Linz W; Schölkens BA; Ganten D
Clin Exp Hypertens A; 1989; 11(7):1325-50. PubMed ID: 2530011
[TBL] [Abstract][Full Text] [Related]
7. Regulation of extracellular matrix proteins in pressure-overload cardiac hypertrophy: effects of angiotensin converting enzyme inhibition.
Grimm D; Kromer EP; Böcker W; Bruckschlegel G; Holmer SR; Riegger GA; Schunkert H
J Hypertens; 1998 Sep; 16(9):1345-55. PubMed ID: 9746122
[TBL] [Abstract][Full Text] [Related]
8. ACE inhibition reduces left ventricular mass independent of pressure without affecting coronary flow and flow reserve in spontaneously hypertensive rats.
Kaneko K; Susic D; Nunez E; Frohlich ED
Am J Med Sci; 1997 Jul; 314(1):21-7. PubMed ID: 9216436
[TBL] [Abstract][Full Text] [Related]
9. Dual ACE and NEP inhibitor MDL-100,240 prevents and regresses severe angiotensin II-dependent hypertension partially through bradykinin type 2 receptor.
Rossi GP; Cavallin M; Rizzoni D; Bova S; Mazzocchi G; Agabiti-Rosei E; Nussdorfer GG; Pessina AC
J Hypertens; 2002 Jul; 20(7):1451-9. PubMed ID: 12131544
[TBL] [Abstract][Full Text] [Related]
10. Raised blood pressure, not renin-angiotensin systems, causes cardiac fibrosis in TGR m(Ren2)27 rats.
Bishop JE; Kiernan LA; Montgomery HE; Gohlke P; McEwan JR
Cardiovasc Res; 2000 Jul; 47(1):57-67. PubMed ID: 10869530
[TBL] [Abstract][Full Text] [Related]
11. Coronary microvasculature alteration in hypertensive rats. Effect of treatment with a diuretic and an ACE inhibitor.
Levy BI; Duriez M; Samuel JL
Am J Hypertens; 2001 Jan; 14(1):7-13. PubMed ID: 11206683
[TBL] [Abstract][Full Text] [Related]
12. Lack of correlation of hypotensive effects with prevention of cardiac hypertrophy by perindopril after ligation of rat coronary artery.
Chiba K; Moriyama S; Ishigai Y; Fukuzawa A; Irie K; Shibano T
Br J Pharmacol; 1994 Jul; 112(3):837-42. PubMed ID: 7921610
[TBL] [Abstract][Full Text] [Related]
13. Cardiac growth during high and low dose perindopril treatment in spontaneously hypertensive rats.
Black MJ; Bertram JF; Johnston CI
Clin Exp Pharmacol Physiol; 1996; 23(6-7):605-7. PubMed ID: 8800599
[TBL] [Abstract][Full Text] [Related]
14. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.
Linz W; Wiemer G; Gohlke P; Unger T; Schölkens BA
Pharmacol Rev; 1995 Mar; 47(1):25-49. PubMed ID: 7784479
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-converting enzyme inhibition improves cardiac function. Role of bradykinin.
Gohlke P; Linz W; Schölkens BA; Kuwer I; Bartenbach S; Schnell A; Unger T
Hypertension; 1994 Apr; 23(4):411-8. PubMed ID: 8144208
[TBL] [Abstract][Full Text] [Related]
16. Experimental evidence for effects of ramipril on cardiac and vascular hypertrophy beyond blood pressure reduction.
Linz W; Gohlke P; Unger T; Schölkens BA
Arch Mal Coeur Vaiss; 1995 Feb; 88 Spec No 2():31-4. PubMed ID: 7646309
[TBL] [Abstract][Full Text] [Related]
17. Prevention of angiotensin II induced myocyte necrosis and coronary vascular damage by lisinopril and losartan in the rat.
Kabour A; Henegar JR; Devineni VR; Janicki JS
Cardiovasc Res; 1995 Apr; 29(4):543-8. PubMed ID: 7796449
[TBL] [Abstract][Full Text] [Related]
18. Vascular and cardiac protection by ramipril in spontaneously hypertensive rats: prevention versus regression study.
Gohlke P; Linz W; Schölkens B; Van Even P; Martorana P; Unger T
Br J Clin Pract Suppl; 1996 Jul; 84():1-10. PubMed ID: 8994995
[TBL] [Abstract][Full Text] [Related]
19. Diuretic herb Gomphrena celosioides Mart. (Amaranthaceae) promotes sustained arterial pressure reduction and protection from cardiac remodeling on rats with renovascular hypertension.
de Paula Vasconcelos PC; Tirloni CAS; Palozi RAC; Leitão MM; Carneiro MTS; Schaedler MI; Silva AO; Souza RIC; Salvador MJ; Junior AG; Kassuya CAL
J Ethnopharmacol; 2018 Oct; 224():126-133. PubMed ID: 29842964
[TBL] [Abstract][Full Text] [Related]
20. Regression of ventricular and vascular hypertrophy: are there differences between structurally different angiotensin-converting enzyme inhibitors?
Raasch W; Bartels T; Schwartz C; Häuser W; Rütten H; Dominiak P
J Hypertens; 2002 Dec; 20(12):2495-504. PubMed ID: 12473875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
